All Clarivate websites use cookies to improve your online experience. They were placed on your computer when you launched this website. You can change your cookie settings through your browser.

More information on our cookie policy.

BioWorld. Link to homepage.

Clarivate
  • BioWorld
  • BioWorld MedTech
  • BioWorld Asia
  • BioWorld Science
  • Data Snapshots
    • BioWorld
    • BioWorld MedTech
  • Special reports
    • Aging
    • Biosimilars
    • Artificial intelligence
    • Coronavirus
    • IVDs on the rise
    • Science '22 in Review
    • Top Biopharma Trends of 2022
    • Top Med-tech Trends of 2022
    • Premium reports
      • BioWorld Financings Reports
      • Disease Incidence & Prevalence Summaries

BioWorld. Link to homepage.

  • Sign In
  • Sign Out
  • My Account
Subscribe
BioWorld - Wednesday, February 1, 2023
Home » Topics » Infection » Coronavirus

Coronavirus
Coronavirus RSS Feed RSS

Financings for March 4, 2020

March 4, 2020
No Comments
Biopharmas raising money in public or private financings, including: Akari Therapeutics, Amunix Pharmaceuticals, Bridgebio Pharma, Cinclus Pharma Holding, Imara, Novan, Pacylex, Tonix, Vaxil, Zogenix.
Read More

Regulatory front for March 3, 2020

March 3, 2020
No Comments
The latest global regulatory news, changes and updates affecting medical devices and technologies.
Read More

India’s restriction on API exports gives rise to more calls for U.S. drug, device manufacturing

March 3, 2020
By Mari Serebrov
No Comments
Against the backdrop of the global spread of COVID-19, India announced restrictions Tuesday on the export of 26 active pharmaceutical ingredients (APIs) and formulations of those ingredients.
Read More
COVID-19 market impact illustration: coronavirus, currency symbols, line graph

Global spread of coronavirus puts financial markets into a tailspin

March 3, 2020
By Peter Winter
No Comments
Concerns about the escalating global spread of COVID-19 panicked the markets big time at the close of the month. With investors rushing to the sidelines, it only took five days for the Dow Jones Industrial Average to drop more than 10% from its all-time high, getting close to the 30,000 mark.
Read More

Other news to note for March 3, 2020

March 3, 2020
No Comments
Biopharma happenings, including deals and partnerships, grants, preclinical data and other news in brief: Abbvie, Allergan, Amgen, Asklepios, Astrazeneca, Avectas, Bionomics, Celldex, Cytokinetics, Cytoo, Domain, Gilead, Heat, Iktos, Inovio, Mediwound, Nanosurface, Ocugen, Pluristem, Siga, SRI, Turnstone, Xphyto.
Read More

Other news to note for March 2, 2020

March 2, 2020
No Comments
Med-tech happenings, including deals and partnerships, grants, preclinical data and other news in brief: Alibaba, Bactiguard, Co-Diagnostics, Convatec, Diasorin, Implandata, Insulet, Lucid Diagnostics, Neogenomics, Pavmed, The Technology Partnership Vigilenz, Vivalnk.
Read More

With pressure on, pharma companies update COVID-19 efforts

March 2, 2020
By Michael Fitzhugh
No Comments
Under steady pressure to accelerate development of vaccines against SARS-CoV-2 and treatments for COVID-19 as the global death toll reached 3,085 people on the afternoon of March 2, biopharma companies continued to detail progress, including in updates at a White House meeting between pharmaceutical executives and administration officials, including President Donald Trump.
Read More
Cancer cell, DNA illustration

Todos Medical sets sights on COVID-19 test market

March 2, 2020
By Meg Bryant
No Comments
New York and Rehovot, Israel-based in vitro diagnostics startup Todos Medical Ltd. is developing blood tests for the early detection of cancer and neurodegenerative diseases using Fourier-transform infrared (FTIR) spectroscopy. Now the company is looking to apply the technology in diagnosing infections, including the novel coronavirus, COVID-19.
Read More
Empty prescription drug bottles

COVID-19 a fulcrum to push MEDS Act through Congress

March 2, 2020
By Mari Serebrov
No Comments
COVID-19 is bringing more pressure to bear on Congress to pass S. 2723, the Mitigating Emergency Drug Shortages (MEDS) Act, which has been sitting in the Senate Health, Education, Labor and Pensions (HELP) Committee since Sen. Susan Collins (R-Maine) introduced it in October 2019 – a few months before the novel coronavirus emerged.
Read More
Europe under magnifier/petri dish with coronavirus

COVID-19: EU launches response team to coordinate efforts

March 2, 2020
By Nuala Moran
No Comments
LONDON – The EU launched a “Corona” response team, bringing together oversight of all the separate strands put in place to control the virus, as the infection spread to 18 of 27 member states, with 2,100 confirmed cases and 31 deaths.
Read More
Previous 1 2 … 465 466 467 468 469 470 471 472 473 … 495 496 Next

Popular Stories

  • Free access to BioWorld coronavirus articles

    BioWorld
    The articles in this collection are from BioWorld’s ongoing coverage of the COVID-19 coronavirus pandemic. They are available for free with registration. Note...
  • Today's news in brief

    BioWorld
    BioWorld briefs for Jan. 31, 2023.
  • Today's news in brief

    BioWorld MedTech
    BioWorld MedTech briefs for Jan. 31, 2022.
  • Setpoint Medical - vagus nerve stimulation device

    Setpoint Medical lands up to $145M to advance RA implant

    BioWorld MedTech
    Bioelectronic medicine startup Setpoint Medical Corp. raised $80 million in a preferred stock financing co-led by new investors Norwest Venture Partners and...
  • Stem-cells2.png

    J.P. Morgan Healthcare Conference: ‘Bright’ year ahead for cell, gene therapies, says ARM

    BioWorld
    After long years of painstaking work, the commercialization of cell and gene therapies picked up pace in 2022, with multiple approvals. More progress is expected...
black cortellis ad

BioWorld Premium

Enjoy extended coverage for the most complete market view with BioWorld, BioWorld MedTech, and BioWorld Asia in a single, easy to access subscription.

Subscribe
  • BioWorld
    • Today's news
    • Analysis and data insight
    • Clinical
    • Data Snapshots
    • Deals and M&A
    • Financings
    • Newco news
    • Opinion
    • Regulatory
    • Science
  • BioWorld MedTech
    • Today's news
    • Clinical
    • Data Snapshots
    • Deals and M&A
    • Financings
    • Newco news
    • Opinion
    • Regulatory
    • Science
  • BioWorld Asia
    • Today's news
    • Analysis and data insight
    • Australia
    • China
    • Clinical
    • Deals and M&A
    • Financings
    • Newco news
    • Regulatory
    • Science
  • BioWorld Science
    • Today's news
    • Biomarkers
    • Cancer
    • Conferences
    • Endocrine/Metabolic
    • Immune
    • Infection
    • Neurology/Psychiatric
    • Patents
  • More
    • About
    • Archives
    • Article reprints and permissions
    • Contact us
    • Cookie policy
    • Copyright notice
    • Data methodology
    • Podcasts
    • Privacy policy
    • Share your news with BioWorld
    • Staff
    • Terms of use
Follow Us

Copyright ©2023. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing